Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

144 patients *PCR

12th World AIDS Conference

IV infection in Mexican
n vs. rechallenge in HIV
tmentalization of HIV in
ates of Ethiopian AIDS
m xenopi infection in HIV
ion of HIV-seropositive
naive and experienced
therapy in HIV-infected
py/Elderly HIV-infected
V-1 isolated from AIDS
navir (RTV) and d4T in
opies in sera of anergic
n the restorative care of
rospinal fluid (CSF) in
d HIV-2 co-infected TB
ease inhibitors in AIDS
protein I in HIV positive
d saliva of HIV-infected
ral load in HIV-infected
Chagas' diseases in HIV
of life and health in HIV
n a population of AIDS
al patterns among STD
of ganciclovir device in
s from HIV-seropositive
V+SQV) in pre-treated
tations for HIV-infected
cteremia in Israeli AIDS
bitor (PI) in HIV infected
)/Hyperbilirubinemia in
une complexes in AIDS
RT resistance profile of
IV +ve drug addicted
cleosides-experienced
rculosis in HIV-infected
among Ethiopian AIDS
een HIV/AIDS acquired
d biopsy in HIV-infected
ad determination of 700
nistic infections in AIDS
e profile of HIV infected
scopy in HIV-1 infected
cephalopathy (PML) in
e status of HIV-infected
iremia in HIV infected
ral load in HIV-1+/AIDS
I load and CD4 count in
disease in HIV infected
HIV-1 infected children/
atients in Gujarat, India/
and training strategies/
ance in HIV population/
erral center of Karachi/
ation therapy/Mutation
tic infections/Changing
derpoint and situational
V disease - a changing
e 1997/Changes in the
engal, India/Changing
neumonia (PCP)/Wide
oviral therapy induction/
ng injection drug users/
street children of Delhi/
um of New Delhi, India/
viral therapy (HAART)/
rt of 120 HIV+ patients/
CBO) in New York City/
ntiretroviral (AR) drugs:
n (MASM) in Montreal/
n at three time periods/
escent communication/
linical HIV-1 isolates/
stance program clients/
atment of HIV patients:

bservational database/
ementari in HIV/AIDS):
pact on HIV incidence/
s buyers' cooperatives/
hocardiographic study/

SKeyword Abstr
/Response to saquinavir plus two
with hypersensitivity to trimethopr
having sustained response to ZD
/Phenotypic characteristics of hu: Report of four cases/Mycobacte
co-infected with HCV/Effect of zi
/Combination therapy with nevira
/Predictors of long-term virologic
in the era of protease inhibitor the
after prolonged therapy with Prev
with advanced HIV disease/Saqu
with HIV disease/Comparison of
with HIV/AIDS on a rehabilitation i
with HIV infection/Prospective ev
before after TB treatment/Plasm
in a public AIDS referral center in
/Anti-cardiolipin and anti-/2 glyco
/Neutralizing effect of secretory Ig
/Infusion of cryropreserved autolo
in Paraguay/Chagas' diseases in
Through Tibetan herbal medicine
/Evolution of CMV retinitis in a po
and asymptomatic family plannin
with silicone oil filled eyes and C
and HIV-seronegative controls/C
/Preliminary data of a pilot study c: Who, how, why?/Psychiatric and
/Bacteremia in Israeli AIDS
/Predictors of viral load response i
treated with indinavir (IDV)/Hype
and the rationale for an ex vivo im
receiving AZT and either 3TC, ddl
/Evaluation of effectiveness of ant
treated with d4T + 3TC + indinavir
in Denmark/Epidemiology of tub
/Low frequency of HIV-1 subtype
and family and community - Pres
/Diagnostic utility of bone marrow
infected with HIV-1 evaluated in B
during antiretroviral therapy: 12 m
five years apart/Changes in the p
/Gastrointestinal endoscopy in HI
with AIDS/Alpha-interferon (IFN)
with Kaposi's sarcoma in an Afric
/Correlations between spontaneo: Distribution and correlation to LT
with and without treatment from R
with and without opportunistic inf
Pattern of HIV-1 RNA load from birth to sch
of tuberculosis (TB) in HIV infected
and characteristics of clients coun
of drug resistance in HIV populatio
of sexually transmitted diseases at

act
60671
60674
60680
60692
60696
60698
60701
60703
60704
60706
60714
60721
60724
60734
60742
60754
60761
60770
60771
60776
60781
60782
60783
60786
60787
60791
60793
60800
60805
60808
60831
60854
60868
60875
60876
60879
60887
60915
60941
60947
60948
60949
60963
60970
60975
60979
60991
60995
13361
22162
24341
41221
60243
12257
13245
23365
32264
42451
43491
60601
12402
13322
14166
14317
221 */21176
22355
22366
22396
23117
23404
33465
230*/42195
42298

42303
42310
42378
575*/43476
60569
60995
11125

- Keyword Abstract --
irteen years/Changing of AIDS due to antiretroviral thera 12117
AIDS in Ukraine/Clinical of HIV-infection/AIDS in Ukraine/ 12149
ch Republic/Changing of HIV/AIDS spread in the Czech 13354
es, Argentina/Disease and survival in children with AIDS 13375
linic/Sexual behaviour and profiles of male STD patients 14104
and high risk behaviour in Hosur, Tirupur and Thirucheng 14123
ng gay men/Long-term in casual sexual behaviour, recre 14144
rminants of changes in of unprotected anal intercourse ( 14204
angerous behavioral in teenage boy sex workers and t 28*/14258
ges in sexual behavior among Asian, Black, Hispanic, a 14330
repertoire/Distinctive of CD8 T cell clonal dominance id 212*/21106
e United States/Recent of antiretroviral prescriptions am 22370
in Scotland/Changing in use of antiretroviral combinatio 22394
stems to assess spatial of drug use, selection bias, and at 23217
on of HIV risk-behavior and implications for behavioral int 23227
on strategies/Temporal of prenatal HIV testing and perina 23317
ence and sexual mixing among ethnic groups in Amsterd 23518
e US study/Variation in of methamphetamine use and HI 24107
hanging HIV treatment in Ontario, Canada/An economic 24129
d gender differentials in of HIV/AIDS hospitalisation and 24191
he effects of HIV testing on reactions to HIV+ diagnosis/T 24266
eview of HIV disclosure at a London teaching hospital/To 24329
hibitor (RTI) resistance in cerebrospinal fluid (CSF) comp 563*/32284
y/Genotypic resistance in HIV-infected naive patients rec 32304
n regimen/Adherence in patients with symptomatic Myc 32324
REACH II)/Changing in injection practices and other dr 33394
n outcomes, costs and of therapy/Impact of drug non-co 42173
erapy (CT): Changes in of use among HIV clinic patients/ 42379
ning/Provider practice: A 9-year retrospective evaluatio 42416
/Changes in HIV/AIDS of care and estimated costs at an 442*/42430
al strategies/Changing of HIV patients management: Co 42440
a City/Knowledge and of condom use among commerci 43365
n ethnographic study of of self-disclosure of HIV status to 44186
1996-1997/Amounts, and trends of national and interna 647*/44232, CA/Adolescent IDUs' of utilization of a storefront needl 60545
ealth seeking behavior of Remedios AID hotline's clients 60759
difference/Community of care for HIV disease: Experien 60779
ctions and behavioural among STD patients and asympt 60783
od are equivalent to the PBMC-based assay/Cytokine and chemo 21184
competitive RT-PCR in PBMC of HIV-infected patients/Semiquant 21181
yte activity using frozen and correlation with disease progre 31156
/Conserved function of from healthy blood donors and PBM 41249
hibits HIV replication in /Methionine enkephalin: a new cyto 60525
culture is diminished in of HIV-1 infected individuals: Longit 60796
injection of autologous PBMCs ex vivo infected with a recombinan 11243
ameters in plasma and in naive patients with CD4+ T cells 22383
ood mononuclear cells ( ) from HIV-2+ individuals resist in v 31154
peripheral blood cells ( ) in HIV+ women and HIV-controls 31196
ween in-hospital TB and PBP experience and quality of HIV-related 42216
0 V3 region is reducing PC 12 neuronal cell line viability/A pentape 60334
dy/Can prophylaxis for PCP and cerebral toxoplasmosis be safely 12268
ystis carinii pneumonia ( )/Patient and provider noncompliance 13234
stis carinii pneumonia ( ): Effects of baseline prophylaxis on sa 22178
s it safe to stop primary prophylaxis in patients treated with an 22180
of P. carinii pneumonia ( ) and toxoplasmic encephalitis (TE)/A 22181
stis carinii pneumonia ( ) prophylaxis after HAART in patients 22186
ated with breakthrough /Risk factors associated with breakthr 22187
stis carinii pneumonia ( ) and acute respiratory failure (ARF)/ 22188
stis carinii pneumonia ( ) and acute respiratory failure (ARF)/ 22436
or for HIV disease/The index: An access and quality of care i 24185
essed rats during acute /Extrapulmonary dissemination of Pn 31220
stis carinii pneumonia ( )/Wide pattern of chest radiographic a 60601
ystis carinii pneumonia ( ) in HIV-infected individuals/Failure of 60797
rapy/Comparison of a PCR-based assay and the MT2 coculture 42192
idization to HIV-1 using PCR-generated, single-stranded, subgen 41159
r typing HIV-1 (B, E) by PCR: Chronological shift of subtype distrib 13138

pattern of the RT and protease genes in HI
of opportunistic infections/Changi
or STD, HIV/AIDS/AIDS awarene?/Manifestation of HIV-associated
of hospital services used by HIV p
of HIV infection in some risk group
of chest radiographic abnormalitie
Patterns of nausea with combination antir
of longitudinal HIV-1 viral load aft
of risk behaviour among street ch
and determinants of sexual beha
of cytokine production analysed a
of antiretroviral therapy (ART) us
of antiretroviral use in a symptom
in five large out-patients departm
of oral sex among men who have
of condom use reported by HIV in
of condom use among adolescen
of phenotypic and genotypic cros
of utilization of antiretroviral thera
of use and efficacy data in the Fre
of protease inhibitor use by healt
of complementary treatments us
of participation in mass STD treat
of therapeutic marijuana use in t
of heart disease in HIV infected p

merase chain reaction (
nscription/competitive
ytomegalovirus (CMV)se chain reaction (QCen testing compared to
uantitative HIV-1 RNA
merase chain reaction (
HIV-1 DNA/A high input
mes/A multiplex nested
rimental Amplicor DNA
merase chain reaction (
een HIV-1 and HIV-2 by
hailand/RNA and DNA
IV-1 seroconvertors by

) in Taiwan/Rapid detection of HIV-1 s
using a newly constructed multispecif
and pp-65 for the detection of CMV-di
)/Comparison of the amount of HPV 1
for diagnosis of pediatric HIV-1 infecti
assay in persons infected with HIV-1
)/Ultrasensitive HIV detection and qu
method (Mega-PCR) for the detection
assay for the detection of six clinically
assay for the detection of HIV-1 DNA i
)/Neurological complications of HIV a
of serologically double reactive sampl
for early diagnosis of infants born to H
in antibody-negative pooled sera/Det

13146
21177
22241
624*/22311
32442
41127
41139
41150
41151
41155
41156
41160
166*/42106
42107

erase processivity and patterns of pausing/Dominance of the E8